Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab

The aim of this study was to assess the utility of neutrophil-to-lymphocyte ratio (NLR), plate-let-to-lymphocyte ratio (PLR), and systemic immune inflammation index (SII) as predictive biomarkers with oncological outcomes for metastatic renal cell carcinoma (mRCC) patients treated with nivolumab and...

Descripción completa

Detalles Bibliográficos
Autores principales: Iinuma, Koji, Enomoto, Torai, Kawada, Kei, Fujimoto, Shota, Ishida, Takashi, Takagi, Kimiaki, Nagai, Shingo, Ito, Hiroki, Kawase, Makoto, Nakai, Chie, Kawase, Kota, Kato, Daiki, Takai, Manabu, Nakane, Keita, Kameyama, Koji, Koie, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617687/
https://www.ncbi.nlm.nih.gov/pubmed/34830607
http://dx.doi.org/10.3390/jcm10225325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617687/
https://www.ncbi.nlm.nih.gov/pubmed/34830607
http://dx.doi.org/10.3390/jcm10225325

Ejemplares similares